Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MI078 in Postpartum Depression
NCT06963580Phase 2Completed
- Sponsor
- Nanjing Minova Pharmaceutical
- Start
- Sep 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MI078 in postpartum depression (PPD), sponsored by Nanjing Minova Pharmaceutical. Started Sep 2024; status: completed.
02
Drugs
MI078
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT06963580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06963580.